Project GMMG-HD6 – A randomized phase III trial on the effect of elotuzumab in VRD inuction / consolidation and…

Basic data

Acronym:
GMMG-HD6
Title:
A randomized phase III trial on the effect of elotuzumab in VRD inuction / consolidation and lenalidomide maintainance in patients with newly diagnosed myeloma
Duration:
07/07/2015 to 31/10/2021
Abstract / short description:
A randomized phase III trial on the effect of elotuzumab in VRD inuction / consolidation and lenalidomide maintainance in patients with newly diagnosed myeloma
Keywords:
Multiples Myelom
Elotuzumab
Lenalidomide

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Internal Medicine Department II
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

Heidelberg, Baden-Württemberg, Germany
Heidelberg, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.